Daily non-political popular news in brief.

Drug treatment seekers more likely to use needle exchange

In an examination of the connection between Baltimore City's needle exchange program and drug treatment programs, researchers from the Johns Hopkins Bloomberg School of Public Health found that individuals who enter treatment programs for drug addiction were more likely to be HIV-positive females who use Baltimore City needle exchange programs.

Read more »

Keywords: drug, treatment, seekers, likely, needle, exchange, seeker

« Previous | Next »

Similar news on "Drug treatment seekers more likely to use needle exchange":

1. Molecular signature may identify cisplatin-sensitive breast tumors
   04-19-2007 · EurekAlert!
   Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors. They also have discovered the molecular basis of this sensitivity, which may help identify patients most likely to benefit from cisplatin treatment.
   Similar news · Read more »
   
2. Common preterm labor drug has more side effects than alternative
   06-29-2007 · EurekAlert!
   The drug most commonly used to arrest preterm labor, magnesium sulfate, is more likely than another common treatment to cause mild to serious side effects in pregnant women, according to a study from researchers at Lucile Packard Children's Hospital and Stanford University School of Medicine.
   Similar news · Read more »
   
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
   09-10-2007 · EurekAlert!
   A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse and the National Cancer Institute, part of the National Institutes of Health. People with this variant were less likely than those without it to have resumed smoking six months after treatment with bupropion.
   Similar news · Read more »
   
4. Drug industry increasingly influences breast cancer research
   02-26-2007 · EurekAlert!
   Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
   Similar news · Read more »
   
5. Common rheumatoid arthritis treatment shows potential for diabetes prevention
   07-10-2007 · EurekAlert!
   Fewer rheumatoid arthritis patients treated with the drug hydroxychloroquine went on to develop diabetes compared to those who never took the drug, according to a 20-plus-year University of Pittsburgh School of Medicine-led study reported today in the Journal of the American Medical Association. In addition, those using HCQ were less likely to take medications to manage diabetes after diagnosis. The study found risk declined a dramatic 77 percent after four years of HCQ treatment.
   Similar news · Read more »
   
6. Men more likely to benefit from clot-busting stroke treatment
   03-12-2007 · EurekAlert!
   Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
7. Resistant HIV quickly hides in infants' cells
   04-30-2007 · EurekAlert!
   New evidence shows that drug-resistant virus passed from mother-to-child can quickly establish itself in infants’ CD4+ T cells where it can hide for years, likely limiting their options for future treatment. The study is published in the May 15 issue of The Journal of Infectious Diseases, now available online.
   Similar news · Read more »
   
8. Enzyme may hold key to new treatment of diabetic kidney disease
   11-07-2006 · EurekAlert!
   Northwestern University researchers have found an enzyme, called "ACE2," may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.
   Similar news · Read more »
   
9. Targeting leukemic stem cells by Bcl-2 inhibition
   11-17-2006 · EurekAlert!
   Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.
   Similar news · Read more »
   
10. Drug treatment slows macular vision loss in diabetics
    12-15-2006 · EurekAlert!
    A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, Johns Hopkins Wilmer Eye Institute scientists report.
    Similar news · Read more »